Menu
Natdac-60-mg

Natdac 60mg

Daclatasvir is the first-in-class NS5A inhibitor used in combination with Sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection.

Compare

Daclatasvir is the first-in-class NS5A inhibitor used in combination with Sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection.

Product

Anti Hepatic

Company

Natco

There are no reviews yet.

Be the first to review “Natdac 60mg”